ChartRow logo
Data provided bySource: Twelve Data
BBIO
$76.80-0.72%
as of close, Nov 17, 2026
☾ AH $76.80 -0.72%
PeersASNDRVMDARGXINCYRPRXGH
Share this page

BridgeBio Pharma Inc. total returns by year (including dividends)

As of market close, Nov 17, 2026

BridgeBio Pharma Inc. annual returns by year
YearTotal return
2026YTD
+0.4%
2025
+178.8%
2024
-32.0%
2023
+429.8%
2022
-54.3%
2021
-76.5%
2020
+102.9%
2019since Jun 27
+27.2%
Annualized
+15.2%
2020–2026
Average year
+91.4%
6 full years
Best year
+429.8%
2023
Worst year
-76.5%
2021
Positive years
3/6
50% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on BBIO. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is BridgeBio Pharma Inc.'s average annual return?
Since 2020, BridgeBio Pharma Inc. (BBIO) has returned about 15.2% a year (the compound annual growth rate) and an average calendar-year return of 91.4%.
What were BridgeBio Pharma Inc.'s best and worst years?
Over 2020–2026, the best year was 2023 (+429.8%) and the worst was 2021 (-76.5%).
How often is BridgeBio Pharma Inc. up in a year?
3 of the 6 full years since 2020 were positive — about 50% of the time.

More on BridgeBio Pharma Inc.